No statistically significant difference was found in the incidence of recurrent T-ALL genetic aberrations (mutations in NOTCH1 and FBXW7 genes and TAL deletion) in CRLF2-low vs. CRLF2-high patients (Figure 1A and Supplementary Table S2). The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.